Literature DB >> 3942465

Clinically unsuspected pheochromocytomas. Experience at Henry Ford Hospital and a review of the literature.

N K Krane.   

Abstract

Thirty-two histopathologically confirmed pheochromocytomas were diagnosed at Henry Ford Hospital, Detroit, between 1951 and 1982. Eleven (34%) of these cases were clinically unsuspected exhibiting none of the typical symptoms of palpitation, diaphoresis, or headache, and only five were hypertensive. These pheochromocytomas may be discovered during computed tomography of the abdomen while evaluating multiple endocrine neoplasia, abdominal pain, and abdominal masses, or they may present at autopsy, at surgery, or as a mass lesion without paroxysmal symptoms or hypertension. Before 1962, 53% of these tumors were undiagnosed before surgery or autopsy; however, since 1962 only 18% of pheochromocytomas have remained clinically unsuspected. By maintaining a higher index of suspicion and using newer biochemical and imaging techniques, the incidence of clinically unsuspected pheochromocytomas should be reduced.

Entities:  

Mesh:

Year:  1986        PMID: 3942465     DOI: 10.1001/archinte.146.1.54

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  12 in total

Review 1.  Pheochromocytoma as an endocrine emergency.

Authors:  Frederieke M Brouwers; Jacques W M Lenders; Graeme Eisenhofer; Karel Pacak
Journal:  Rev Endocr Metab Disord       Date:  2003-05       Impact factor: 6.514

2.  Emergency operation in a patient with asymptomatic pheochromocytoma.

Authors:  A Nonaka; S Kashimoto; K Okuyama; M Kume; T Funayama; T Kumazawa
Journal:  J Anesth       Date:  1993-10       Impact factor: 2.078

3.  Screening for pheochromocytoma.

Authors:  J Whittle
Journal:  J Gen Intern Med       Date:  1990 Jan-Feb       Impact factor: 5.128

Review 4.  The clinical evaluation of silent adrenal masses.

Authors:  B Ambrosi; E Passini; T Re; L Barbetta
Journal:  J Endocrinol Invest       Date:  1997-02       Impact factor: 4.256

5.  Evaluation of clonidine suppression and various provocation tests in the diagnosis of pheochromocytoma.

Authors:  H Koshida; I Miyamori; R Soma; T Matsubara; S Okamoto; M Ikeda; R Takeda
Journal:  J Endocrinol Invest       Date:  1990-11       Impact factor: 4.256

6.  Frequency of pheochromocytoma in adrenal incidentalomas and utility of the glucagon test for the diagnosis.

Authors:  G P Bernini; M S Vivaldi; G F Argenio; A Moretti; M Sgrò; A Salvetti
Journal:  J Endocrinol Invest       Date:  1997-02       Impact factor: 4.256

Review 7.  Subclinical phaeochromocytoma.

Authors:  Massimo Mannelli; Jacques W M Lenders; Karel Pacak; Gabriele Parenti; Graeme Eisenhofer
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2012-05-22       Impact factor: 4.690

8.  A nonsecreting pheochromocytoma presenting as an incidental adrenal mass. Report on a case.

Authors:  M Mannelli; C Pupilli; R Lanzillotti; L Ianni; A Amorosi; G Credi; C Pratesi
Journal:  J Endocrinol Invest       Date:  1993-11       Impact factor: 4.256

9.  Phaeochromocytoma--a laboratory experience.

Authors:  W P Tormey; R J FitzGerald
Journal:  Ir J Med Sci       Date:  1995 Apr-Jun       Impact factor: 1.568

10.  Case Report: Malignant Pheochromocytoma Without Hypertension Accompanied by Increment of Serum VEGF Level and Catecholamine Cardiomyopathy.

Authors:  Hideaki Kaneto; Shinji Kamei; Fuminori Tatsumi; Masashi Shimoda; Tomohiko Kimura; Shuhei Nakanishi; Yoshiyuki Miyaji; Atsushi Nagai; Kohei Kaku; Tomoatsu Mune
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-25       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.